Chris Hourigan

Chris Hourigan is Company Group Chairman of Janssen Asia Pacific, where he oversees pharmaceutical operations across eight markets in the world’s most diverse and populous region. He is also a member of the Pharmaceuticals Group Operating Committee.

For the five years prior to this appointment, Chris was President of Janssen Japan, the second largest market for Janssen globally. Under his leadership, he improved the company’s market competitiveness, widened access to innovative medicines, and attracted and developed strong talent.

Prior to this role, he held leadership positions in Australia, Vietnam and New Zealand and made a meaningful difference in the lives of patients by working collaboratively with a range of health and pharmaceutical stakeholders to establish access to and foster the quality use of innovative medicines. He also worked in the United States as Global Marketing Lead for the Janssen Psychiatry business unit.

Chris is a highly respected member of the pharmaceutical industry, having chaired Pharmaceutical Research and Manufacturers of America (PhRMA) Japan and served as a board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan, Medicines Australia and Medicines New Zealand to highlight the value of pharmaceutical innovation and advocate for access to medicines.

Chris holds a Master of Business Administration and a Bachelor of Applied Science from the University of Technology, Sydney, Australia.